Scott G

South London and Maudsley NHS Foundation Trust, UK.

2 papers · ORCID

ArticleDMT

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial.

Marsden J, Kelleher M, Dunbar F +8

Europe PMC2025
ArticlePsilocybin

Psychedelics as a treatment for disorders of consciousness.

Scott G, Carhart-Harris RL

Europe PMC2019